According to these studies, silencing P-Rex1 expression from breast cancer cells impairs the activation of Erk, a major driver of mitogenic signaling, thus arguing for the involvement of this Rac-GEF in breast cancer cell proliferation [27–29]. The gene discussed is AKT1; the disease is breast carcinoma.